Advertisement

Dose–response relationship of serum uric acid levels with risk of stroke mortality

      Abstract

      Introduction

      Results from the recent meta-analysis suggested that higher serum uric acid (SUA) levels are positively associated with risk of stroke. However, the relationship of SUA levels with risk of stroke is still unclear.

      Materials and methods

      Data from prospective cohort studies on SUA levels and risk of stroke mortality was used. Dose–response relationship was assessed by restricted cubic spline model and multivariate random effect meta-regression.

      Results

      A non-linear relationship (Pfor non-linearity = 0.004) of SUA levels with risk of stroke mortality was found for men, and the relative risk (RR) with 95% confidence interval (CI) of stroke mortality was 1.00 (0.99–1.01), 0.99 (0.94–1.04), 0.98 (0.91–1.06), 1.00 (0.90–1.12), 1.17 (1.09–1.24) and 1.52 (1.33–1.78) for 2, 3, 4, 5, 6 and 7 mg/dL of SUA levels, respectively. For women, the departure from linearity was not significant (Pfor non-linearity = 0.67), and the RR (95 %CI) of stroke mortality was 1.02 (0.99–1.04), 1.10 (0.97–1.20), 1.15 (0.96–1.37), 1.25 (1.09–1.44), 1.39 (1.28–1.50) for 2, 3, 4, 5, 6 mg/dL of SUA levels, respectively.

      Conclusions

      Different dose–response relationships of SUA levels with risk of stroke mortality might exist for men and for women. Dose–response relationship of SUA levels with risk of stroke incidence needs to be explored.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Li M.
        • Hou W.
        • Zhang X.
        • Hu L.
        • Tang Z.
        Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies.
        Atherosclerosis. 2014; 232: 265-270
        • Dalbeth N.
        • Wong S.
        • Gamble G.D.
        • et al.
        Acute effect of milk on serum urate concentrations: a randomised controlled crossover trial.
        Ann Rheum Dis. 2010; 69: 1677-1682
        • Hu D.
        • Huang J.
        • Wang Y.
        • Zhang D.
        • Qu Y.
        Dairy foods and risk of stroke: a meta-analysis of prospective cohort studies.
        Nutr Metab Cardiovasc Dis. 2013; https://doi.org/10.1016/j.numecd.2013.12.006
        • Desquilbet L.
        • Mariotti F.
        Dose-response analyses using restricted cubic spline functions in public health research.
        Stat Med. 2010; 29: 1037-1057
        • Orsini N.
        • Li R.
        • Wolk A.
        • Khudyakov P.
        • Spiegelman D.
        Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software.
        Am J Epidemiol. 2012; 175: 66-73
        • Orsini N.
        • Bellocco R.
        • Greenland S.
        Generalized least squares for trend estimation of summarized dose–response data.
        Stat J. 2006; 6: 40-57
        • Jackson D.
        • White I.R.
        • Thompson S.G.
        Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses.
        Stat Med. 2010; 29: 1282-1297
        • Holme I.
        • Aastveit A.H.
        • Hammar N.
        • Jungner I.
        • Walldius G.
        Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).
        J Intern Med. 2009; 266: 558-570
        • Strasak A.
        • Ruttmann E.
        • Brant L.
        • et al.
        Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men.
        Clin Chem. 2008; 54: 273-284
        • Gerber Y.
        • Tanne D.
        • Medalie J.H.
        • Goldbourt U.
        Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes.
        Eur J Cardiovasc Prev Rehabil. 2006; 13: 193-198
        • Jee S.H.
        • Lee S.Y.
        • Kim M.T.
        Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men.
        Eur J Cardiovasc Prev Rehabil. 2004; 11: 185-191
        • Sakata K.
        • Hashimoto T.
        • Ueshima H.
        • Okayama A.
        Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980–1994. National Integrated Projects for Prospective Observation of Non-communicable Diseases and its Trend in the Aged.
        Eur J Epidemiol. 2001; 17: 461-468
        • Strasak A.M.
        • Kelleher C.C.
        • Brant L.J.
        • et al.
        Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study.
        Int J Cardiol. 2008; 125: 232-239
        • Hozawa A.
        • Folsom A.R.
        • Ibrahim H.
        • Nieto F.J.
        • Rosamond W.D.
        • Shahar E.
        Serum uric acid and risk of ischemic stroke: the ARIC Study.
        Atherosclerosis. 2006; 187: 401-407
        • Kuo C.F.
        • See L.C.
        • Yu K.H.
        • Chou I.J.
        • Chiou M.J.
        • Luo S.F.
        Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality.
        Rheumatol (Oxford). 2013; 52: 127-134

      Linked Article